Multiple sclerosis
Multiple Sclerosis (MS) is a chronic, autoimmune disease that affects the central nervous system (CNS), particularly the brain and spinal cord. It involves the immune system attacking the protective sheath (myelin) that covers nerve fibers, leading to communication problems between the brain and the rest of the body. Over time, the disease can cause permanent damage or deterioration of the nerves themselves.
Types of Multiple Sclerosis
- Relapsing-Remitting MS (RRMS): Characterized by clear relapses of disease activity followed by periods of partial or complete recovery (remissions). This is the most common form, affecting about 85% of MS patients.
- Secondary Progressive MS (SPMS): Follows an initial relapsing-remitting course. Many people with RRMS eventually transition to SPMS, which is marked by a progressive worsening of neurologic function over time.
- Primary Progressive MS (PPMS): Characterized by steadily worsening neurologic function from the onset of symptoms, without early relapses or remissions. About 10-15% of people with MS are diagnosed with PPMS.
- Progressive-Relapsing MS (PRMS): A rare form of MS, where people experience a steady progression of disease from the beginning with occasional exacerbations.
At Dar EL-MONA Creating an individualized plan of treatment for neurorehabilitation begins with a comprehensive assessment, which informs the development of a tailored individualized intervention strategy.
Each patient’s treatment plan is tailored to their specific needs, considering the severity of their condition, overall health, and rehabilitation goals. Continuous assessment and adjustment of the manual therapy techniques ensure optimal outcomes.